News + Filings Transactions Holdings
All 13F 13D/G Other
|
Flagship Ventures Fund 2004 L P
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2018 |
SC 13G/A
| Flagship Ventures Fund 2004 L P reports a 0% stake in T2 Biosystems, Inc. |
12/13/2017 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on Quanterix Corp
Txns:
| Converted 398,257 shares
@ $0 Converted 1,045,426 shares
@ $0 Converted 477,042 shares
@ $0 Converted 109,770 shares
@ $0 Converted 1,280,000 preferred shares
@ $0 Converted 3,360,000 preferred shares
@ $0 Converted 1,533,214 preferred shares
@ $0 Converted 352,800 preferred shares
@ $0 |
|
12/06/2017 |
3
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 3 on Quanterix Corp |
02/13/2017 |
SC 13G/A
| Flagship Ventures Fund 2004 L P reports a 6.4% stake in T2 Biosystems, Inc. |
02/13/2017 |
SC 13G/A
| Flagship Ventures Fund 2004 L P reports a 0% stake in DNIB Unwind, Inc. |
02/12/2015 |
SC 13G
| Flagship Ventures Fund 2004 L P reports a 11.8% stake in T2 Biosystems, Inc. |
08/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/19/2014 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.
Txns:
| Converted 530,974 shares
@ $0 Converted 93,008 shares
@ $0 Converted 3,000,000 convertible preferred
@ $0 Converted 525,500 convertible preferred
@ $0 |
|
02/10/2014 |
SC 13G
| Flagship Ventures Fund 2004 L P reports a 9.5% stake in BIND Therapeutics, Inc. |
09/27/2013 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on BIND Therapeutics, Inc
Txns:
| Converted 1,542,616 shares
@ $0 Bought 20,000 shares
@ $15, valued at
$300k
Converted 984,640 preferred shares
@ $0 Converted 1,900,000 preferred shares
@ $0 Converted 416,667 preferred shares
@ $0 Converted 333,288 preferred shares
@ $0 Converted 407,060 preferred shares
@ $0 |
|
03/27/2013 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns:
| Converted 72,068 shares
@ $0 Converted 94,003 shares
@ $0 Converted 393,863 shares
@ $0 Converted 331,953 shares
@ $0 Converted 673,962 shares
@ $0 Bought 491,824 shares
@ $7, valued at
$3.4M
Converted 2,090,000 options to buy
@ $0 Converted 2,726,088 options to buy
@ $0 Converted 11,422,045 options to buy
@ $0 Converted 9,626,604 options to buy
@ $0 Converted 19,544,924 options to buy
@ $0 |
|
03/19/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
09/22/2009 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on HELICOS BIOSCIENCES CORP
Txns:
| Bought 242,931 shares
@ $0 Bought 160,821 warrants
@ $2.61, valued at
$419.7k
|
|
08/10/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/29/2008 |
4
| AGTC ADVISORS FUND LP (10% Owner) has filed a Form 4 on HELICOS BIOSCIENCES CORP |
|
|